SMO and melanoma: Moreover, the concentration of SHH dose-dependently augmented in the presence of the SMO antagonist, arguing for an intrinsic tight modulation of the signaling by melanoma cells and the endeavor to counteract its suppression imposed by pharmacological treatment.